Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan:51:101471.
doi: 10.1016/j.smim.2021.101471. Epub 2021 Mar 3.

Residual immune dysfunction under antiretroviral therapy

Affiliations
Review

Residual immune dysfunction under antiretroviral therapy

Catherine W Cai et al. Semin Immunol. 2021 Jan.

Abstract

The usage of combination antiretroviral therapy in people with HIV (PWH) has incited profound improvement in morbidity and mortality. Yet, PWH may not experience full restoration of immune function which can manifest with non-AIDS comorbidities that frequently associate with residual inflammation and can imperil quality of life or longevity. In this review, we discuss the pathogenesis underlying chronic inflammation and residual immune dysfunction in PWH, as well as potential therapeutic interventions to ameliorate them and prevent incidence or progression of non-AIDS comorbidities. Current evidence advocates that early diagnosis and prompt initiation of therapy at high CD4 counts may represent the best available approach for an improved immune recovery in PWH.

Keywords: HIV; Inflammation; Non-AIDS comorbidities.

PubMed Disclaimer

References

    1. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet, 2000. 355(9210): p.1131–7. - PubMed
    1. Palella FJ Jr., et al., Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med, 1998. 338(13): p. 853–60. - PubMed
    1. Antiretroviral Therapy Cohort C, Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet, 2008. 372(9635): p. 293–9. - PMC - PubMed
    1. Zandman-Goddard G and Shoenfeld Y, HIV and autoimmunity. Autoimmun Rev, 2002. 1(6): p. 329–37. - PubMed
    1. Cuellar ML and Espinoza LR, Rheumatic manifestations of HIV-AIDS. Baillieres Best Pract Res Clin Rheumatol, 2000. 14(3): p. 579–93. - PubMed

Publication types